| Time | Session |
|---|---|
|
14:00
15:00
|
Ballroom 4, Lower Ground Floor
|
| Time | Session |
|---|---|
|
08:30
09:00
|
The Future of Respiratory and Critical Care: Scaling The 4P Approach To Clinical Trials
The 4P approach in medicine includes prevention, prediction, personalization and patient participation. This 4P approach is already being scaled to critical care clinical trials. Prevention for critical illness exist at different levels across the continuum of critical illness The new global ARDS definition, which now permits earlier enrolment of non-intubated patients allows for trials aimed at prevention of intubation and indeed, recent "positive" trials have consequently enrolled hospitalized patients before mechanical ventilation. Because most patients never develop the disease, prevention demands prediction which serves as enrichment strategies in clinical trials to identify patients for trial enrollment. Two enrichment strategies include prognostic enrichment (selecting for higher event rates, e.g. severe ARDS with PaO₂/FiO₂ < 150 mmHg) and predictive enrichment (selecting patients more likely to respond biologically). Predictive enrichment also leads to precision medicine which is already occurring in ARDS trials. The final 4P is patient participation, covering patient-reported outcomes in post-intensive care syndrome and equity in enrollment into clinical trial participation.
Ballroom 3, Lower Ground Floor
|